Safety and efficacy of SNS-301 plus pembrolizumab in patients with advanced squamous cell carcinoma of the head and neck (SCCHN)

被引：0
|
作者：
Algazi, Alain Patrick
Smith, William
Bruce, Justine Yang
Shin, Dong Moon
Gramza, Ann Wild
Jelinek, Michael J.
Singh, Jaswinder
Misiukiewicz, Krzysztof
Shah, Dhaval
Campbell, Jean S.
Pierce, Robert Hamilton
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] NOCCR VRG, Knoxville, TN USA
[3] Univ Wisconsin, Madison, WI USA
[4] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[5] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
[6] Rush Univ, Med Ctr, Chicago, IL 60612 USA
[7] Res Med Ctr, Mission Hills, KS USA
[8] Icahn Sch Med Mt Sinai, Hematol & Med Oncol, New York, NY 10029 USA
[9] Med Oncol Hematol Consultants, Newark, DE USA
[10] Sensei Biotherapeut, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18009
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase 1, open-label study (EGF 100262) of lapatinib plus chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    El-Hariry, I.
    Harrington, K.
    Bourhis, J.
    Holford, C.
    RADIOTHERAPY AND ONCOLOGY, 2007, 82 : S30 - S30
  • [42] A phase I/II study of oncolytic reovirus plus carboplatin/paclitaxel in patients with advanced solid cancers with emphasis on squamous cell carcinoma of the head and neck(SCCHN)
    Karapanagiotou, E. M.
    Chester, J. D.
    Pandha, H. S.
    Gill, G. M.
    Coffey, M. C.
    Mettinger, K.
    Harrington, K. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [43] Characterization of the tumor immune microenvironment in head and neck squamous cell carcinoma (SCCHN)
    Succaria, Farah
    Kvistborg, Pia
    Engle, Elizabeth L.
    McMiller, Tracee L.
    Thompson, Elizabeth
    Berger, Alan E.
    Haanen, John
    Topalian, Suzanne L.
    Taube, Janis M.
    CANCER RESEARCH, 2018, 78 (13)
  • [44] Efficacy of pembrolizumab-chemotherapy vs. cetuximabchemotherapy in head and neck squamous cell carcinoma
    Jeanice, T.
    Gunawan, C. M. A.
    Liem, E. C.
    Gunawan, Y. R.
    Evangelista, I. D.
    Sukendro, G. M.
    Kurniawan, A.
    Huang, I.
    ANNALS OF ONCOLOGY, 2024, 35 : S1402 - S1402
  • [45] A phase 1b/2 trial of lenvatinib plus pembrolizumab in patients with squamous cell carcinoma of the head and neck
    Taylor, Matthew H.
    Rasco, Drew W.
    Brose, Marcia S.
    Vogelzang, Nicholas J.
    Richey, Stephen L.
    Cohen, Allen L.
    Richards, Donald A.
    Stepan, Daniel E.
    Dutcus, Corina E.
    Guo, Matthew
    Shumaker, Robert C.
    Schmidt, Emmett V.
    Young, Louise
    Wirth, Lori J.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 174 - 174
  • [46] A phase III trial of nolatrexed versus methotrexate in patients (pts) with advanced or recurrent squamous cell carcinoma of the head and neck (SCCHN)
    Pivot, X
    Kelly
    Tortochaux
    Belpomme
    Humblet
    Domenge
    Johnston, A
    Clindenann, N
    Penning, C
    Schneider, M
    ANNALS OF ONCOLOGY, 1998, 9 : 74 - 75
  • [47] Predictive biomarkers and EGFR inhibitors in squamous cell carcinoma of head and neck (SCCHN)
    Vigneswara, V.
    Kong, A.
    ANNALS OF ONCOLOGY, 2018, 29 (04) : 794 - 796
  • [48] ECONOMIC BURDEN OF SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) IN THE UNITED STATES
    Berger, A.
    Contente, M.
    Kumar, N.
    Abraham, P.
    Shah, R.
    Shah, S.
    Singh, P.
    VALUE IN HEALTH, 2019, 22 : S65 - S65
  • [49] Efficacy and Safety of Gefitinib in Patients with Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis of Randomized Controlled Trials
    Tang, Xiaoxia
    He, Juan
    Li, Bo
    Zheng, Yi
    Li, Kejia
    Zou, Shun
    Chen, Long
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [50] Safety and efficacy of pembrolizumab with chemotherapy in locally advanced head and neck cancers
    Patil, Vijay
    Alone, Mitali
    Rai, Rahul
    Noronha, Vanita
    Menon, Nandini
    Prabhash, Kumar
    ORAL ONCOLOGY, 2022, 127
12345